NEXAVAR vs TAGRISSO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. NEXAVAR and TAGRISSO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	NEXAVAR	TAGRISSO
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	SORAFENIB TOSYLATE	OSIMERTINIB MESYLATE
Manufacturer	Bayer Hlthcare	Astrazeneca
Dosage forms	Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Neoplasms	Non-Small-Cell Lung Carcinoma

nexavar tagrisso

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

SORAFENIB TOSYLATE

OSIMERTINIB MESYLATE

Manufacturer

Bayer Hlthcare

Astrazeneca

Dosage forms

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Neoplasms

Non-Small-Cell Lung Carcinoma

Frequently asked questions

What is the difference between Nexavar and Tagrisso?

Nexavar contains Sorafenib Tosylate, while Tagrisso contains Osimertinib Mesylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.